Qtoglym-M2 Tablet PR
Prescription Required
Uses of Qtoglym-M Tablet PR
Side effects of Qtoglym-M Tablet PR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Qtoglym-M
- Nausea
- Dryness in mouth
- Upset stomach
How to use Qtoglym-M Tablet PR
Use it as advised by your doctor or check the label for directions before use. Qtoglym-M2 Tablet PR is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Qtoglym-M2 Tablet PR.
Pregnancy
CONSULT YOUR DOCTOR
Qtoglym-M2 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Qtoglym-M2 Tablet PR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
Qtoglym-M2 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Qtoglym-M2 Tablet PR may be needed. Please consult your doctor.
Use of Qtoglym-M2 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Use of Qtoglym-M2 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CAUTION
Qtoglym-M2 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Qtoglym-M2 Tablet PR may be needed. Please consult your doctor.
Qtoglym-M2 Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Qtoglym-M2 Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.Marketer details
Name: Shashvat Healthcare
Address: C-366, Siddharth Nagar, Malviya Nagar, Near Airport Terminal 2, Jaipur 302017
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹65
Inclusive of all taxes
10.0 Tablet pr in 1 strip
SOLD OUT
Notify me